Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Walz

Showing results (141-150 of 212) with videos related to

Pageof 22
Sort By:
Urology Practice|November 7, 2024
Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and UrologistsArnulf Stenzl, Andrew J Armstrong, Eamonn Rogers, et al.
World Journal of Urology|February 22, 2023
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failureGéraldine Pignot, Michael Baboudjian, Cédric Lebacle, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2009
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomyHendrik Isbarn, Pierre I Karakiewicz, Jochen Walz, et al.
European Urology|January 9, 2020
Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al.
European Radiology|May 15, 2021
ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imagingTobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
European Urology|January 18, 2006
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Thierry Lebeau, et al.
BJU International|November 17, 2007
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancerAlberto Briganti, Andrea Gallina, Nazareno Suardi, et al.
Journal of Endourology|March 22, 2008
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sumPierre I Karakiewicz, Felix K-H Chun, Andrea Gallina, et al.
European Urology|October 30, 2007
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliterSascha A Ahyai, Markus Graefen, Thomas Steuber, et al.
Cancer Research|May 20, 2016
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor ActivityChristine Pasero, Gwenaëlle Gravis, Mathilde Guerin, et al.
Pageof 22

Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
Urology Practice|November 7, 2024
Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and UrologistsArnulf Stenzl, Andrew J Armstrong, Eamonn Rogers, et al.
World Journal of Urology|February 22, 2023
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failureGéraldine Pignot, Michael Baboudjian, Cédric Lebacle, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2009
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomyHendrik Isbarn, Pierre I Karakiewicz, Jochen Walz, et al.
European Urology|January 9, 2020
Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al.
European Radiology|May 15, 2021
ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imagingTobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
European Urology|January 18, 2006
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Thierry Lebeau, et al.
BJU International|November 17, 2007
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancerAlberto Briganti, Andrea Gallina, Nazareno Suardi, et al.
Journal of Endourology|March 22, 2008
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sumPierre I Karakiewicz, Felix K-H Chun, Andrea Gallina, et al.
European Urology|October 30, 2007
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliterSascha A Ahyai, Markus Graefen, Thomas Steuber, et al.
Cancer Research|May 20, 2016
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor ActivityChristine Pasero, Gwenaëlle Gravis, Mathilde Guerin, et al.
Pageof 22